GenMont Biotech Incorporation (TPE:3164)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
16.60
+0.20 (1.22%)
May 29, 2026, 1:30 PM CST
Market Cap1.43B -18.3%
Revenue (ttm)401.23M +6.1%
Net Income57.20M +15.2%
EPS0.66 +15.7%
Shares Out 86.01M
PE Ratio25.15
Forward PEn/a
Dividend0.80 (4.82%)
Ex-Dividend DateApr 8, 2026
Volume253,989
Open16.40
Previous Close16.40
Day's Range16.00 - 16.60
52-Week Range16.05 - 22.40
Beta0.12
Analystsn/a
Price Targetn/a
Earnings DateMay 15, 2026

About TPE:3164

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 3164
Full Company Profile

Financial Performance

In 2025, TPE:3164's revenue was 401.23 million, an increase of 4.11% compared to the previous year's 385.37 million. Earnings were 57.20 million, a decrease of -0.09%.

Financial Statements